References
- Marsh S. The top 10 most locked down places in the world. 9 NEWS [Internet]. 2021; 04 October 2021 [cited 2022 January 01]. National News: [11 pages]. https://www.9news.com.au/national/coronavirus-top-10-most-locked-down-places-in-the-world/b7852ef6-9667-40a4-81a0-a99d70cc45ad
- Health.gov.au [Internet]. Australia: Department of Health; [cited 14 March 2021]. https://www.health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov-health-alert/coronavirus-covid-19-current-situation-and-case-numbers#total-cases-recoveries-and-deaths
- Saul A, Scott N, Crabb BS, et al. Impact of victoria's stage 3 lockdown on COVID-19 case numbers. Med J Aust. 2020 Dec;213(11):494–496 e1.
- Te Marvelde L, Wolfe R, McArthur G, et al. Decline in cancer pathology notifications during the 2020 COVID-19-related restrictions in Victoria. Med J Aust. 2021 Apr;214(6):281–283.
- Milne GJ, Xie S, Poklepovich D, et al. A modelling analysis of the effectiveness of second wave COVID-19 response strategies in Australia. Sci Rep. 2021;11(1):11958. 7
- Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
- Raman HS, Flamand Y, Luskin MR, et al. Clinical characteristics and outcomes of patients with newly diagnosed De novo acute myeloid leukemia (AML) during the COVID-19 pandemic. Blood. 2021;138(Supplement 1):2291–2291.
- Weinkove R, McQuilten ZK, Adler J, et al. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust. 2020;212(10):481–489.
- Wei AH. Fitness for intensive chemotherapy: a continuing conundrum. Blood. 2021;138(5):356–358.
- Mitrovic M, Pantic N, Sabljic N, et al. Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality. Leukemia & Lymphoma. 2021;62(14):3516–3520.
- Demichelis-Gómez R, Alvarado-Ibarra M, Vasquez-Chávez J, et al. Treating acute leukemia during the COVID-19 pandemic in an environment with limited resources: a multicenter experience in four Latin American countries. J Clin Oncol Global Oncol. 2021;7:577–584.
- Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1305–1309.
- McNab S, Do H, Clifford LA, et al. Changing epidemiology of respiratory syncytial virus in Australia - delayed re-emergence in Victoria compared to WA/Nsw after prolonged lock-down for COVID-19. Clin Infect Dis. 73(12):2365–2366.
- Miller JH, Opat SS, Shortt J, et al. Impact of coronavirus disease 2019 (COVID-19) pandemic isolation measures on the rate of non-COVID-19 infections in hematology patients. Infect Control Hosp Epidemiol. 2021;42(2):233–235.
- Eyre TA, Peters L, Andersson MI, et al. Reduction in incidence of non-COVID-19 respiratory virus infection amongst haematology inpatients following UK social distancing measures. Br J Haematol. 2021;195(2):194–197.